| Updated Policies | Glofitamab-gxbm (Columvi) | MA08.163b | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies | MA00.002o | | 8/11/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Non-Spinal Osteogenic Stimulators (Electrical and Ultrasonic) | MA05.018d | 8/9/2024 11:00 AM | 9/9/2024 | | | 9/9/2024 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Updated Policies | Computer-Aided Detection (CAD) System for Use with Chest Radiographs | MA09.014b | | 9/9/2024 | | | 9/9/2024 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Ground Ambulance Transport Services (Emergency and Nonemergency) | MA12.002d | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio) | MA08.033d | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Medicare Part B vs. Part D Crossover Drugs | MA08.007an | | 9/1/2024 | | | 9/9/2024 | Medical Coding | | |
| Updated Policies | Hematopoietic Stem Cell Transplantation | MA11.002l | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Prophylactic Mastectomy, Oophorectomy/Salpingo-Oophorectomy, and Hysterectomy | MA11.077g | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Edge-to-Edge Repair (TEER) of the Mitral Valve | MA11.027e | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Retifanlimab-dlwr (Zynyz®) | MA08.161b | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria | | |
| Updated Policies | Vedolizumab (Entyvio®) for Injection for Intravenous Use | MA08.001h | | 9/9/2024 | | | 9/9/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Knee Orthoses | MA05.013h | 8/13/2024 10:00 AM | 9/13/2024 | | | 9/13/2024 | Medical Necessity Criteria | | |
| Updated Policies | Surgical Procedures of the Eyelid and Brow | MA11.047e | 6/18/2024 9:00 AM | 9/16/2024 | | | 9/16/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Abatacept (Orencia®) for Injection for Intravenous Use | MA08.028j | | 9/23/2024 | | | 9/23/2024 | Medical Necessity Criteria | | |
| Reissue Policies | Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aorto-Iliac Aneurysms, and Infrarenal Aortic Aneurysms | MA11.012f | | 1/1/2024 | 9/4/2024 | | 9/4/2024 | | | |
| Reissue Policies | Bioimpedance for the Detection of Lymphedema | MA07.052 | | 12/28/2014 | 9/4/2024 | | 9/4/2024 | | | |
| Reissue Policies | Low-Level Laser Therapy | MA07.036d | | 1/1/2024 | 9/4/2024 | | 9/4/2024 | | | |
| Reissue Policies | Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant Skin | MA11.073d | | 7/11/2021 | 9/4/2024 | | 9/4/2024 | | | |
| Reissue Policies | Emapalumab-lzsg (Gamifant®) | MA08.104b | | 1/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Off-label Coverage for Prescription Drugs and/or Biologics | MA08.012c | | 1/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Enzyme Replacement for the Treatment of Gaucher's Disease | MA08.023c | | 1/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Treatments for Complex Regional Pain Syndrome (CRPS) | MA08.026j | | 4/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Cast and Splint Applications and Associated Supplies | MA00.012c | | 1/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Modifiers XE, XS, XP, XU, and 59 | MA03.005c | | 1/31/2022 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Modifiers 26 (Professional Component) and TC (Technical Component) | MA03.011n | | 7/1/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Inclisiran (Leqvio®) | MA08.149 | | 1/2/2024 | 9/18/2024 | | 9/18/2024 | | | |
| Reissue Policies | Extraction of Bony Impacted Teeth and Exposure of Impacted Teeth | MA04.002 | | 1/1/2024 | 9/18/2024 | | 9/19/2024 | | | |
| Reissue Policies | Transplants and Cranial Prostheses (Wigs) | MA11.046b | | 1/1/2024 | 9/18/2024 | | 9/19/2024 | | | |
| Reissue Policies | Home Prothrombin Time Monitoring | MA05.016h | | 1/1/2024 | 9/18/2024 | | 9/23/2024 | | | |
| Reissue Policies | Otoplasty or Non-Surgical External Ear Molding | MA11.058a | | 1/1/2024 | 9/18/2024 | | 9/23/2024 | | | |
| Coding Update | Acupuncture | MA12.004d | | 10/1/2024 | | | 9/30/2024 | | | |
| Archived Policies | Artificial Intervertebral Lumbar Disc Insertion | MA11.114b | 9/20/2024 11:00 AM | 10/20/2024 | | | 9/20/2024 | | | |
